Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT03155191 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03155191
- Sponsor
- Takara Bio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2035-03-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.